Kerry has reached an agreement to acquire Canadian probiotic company, Bio-K Plus. The acquisition of the latter, which offers probiotic beverage and supplement applications in the North American market, will expand Kerry’s capabilities and position in the probiotics market.
This acquisition expands Kerry’s portfolio of probiotics, and reflects the growing number of consumers who are becoming more proactive in their approach to managing their health and are turning to functional foods, beverages and supplements that are made with functional ingredients. Bio-K Plus products are formulated with three strains of probiotics, which have confirmed efficacy for a range of therapeutic benefits, including the prevention of side effects resulting from antibiotic use, Kerry claimed.
Commenting on the acquisition, Neil Cracknell, president, Kerry Applied Health & Nutrition, said: “Research has shown that consumers are increasingly looking for nutritional benefits when purchasing food and drink, and that products which contain probiotics that improve gut health are specifically in demand. Bio-K Plus further expands our portfolio of probiotics with the addition of three science-backed strains as we continue to help enhance the health and wellness of consumers across the globe by having a strong complement of published clinical trials confirming efficacy.”
Kerry has been developing functional ingredients for several years, with the acquisition of immune health ingredient Wellmune in 2015, followed by probiotic GanedenBC30 in 2017.